SEI Investments’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
NCNMGF
MBAM
SEI Investments's XGN Position: Q3 2026 in Review
SEI Investments reduced its Exagen (XGN) stake by 40% in Q3 2026, selling an estimated $282K and leaving 65,091 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #2609.
SEI Investments first reported a position in XGN in Q4 2025 and has held it in 4 quarters since. The position peaked at $733K in Q1 2026. 78 funds tracked by Wall St. Rank hold XGN as of Q3 2026.
- SEI Investments held 65,091 shares of Exagen worth $529K as of Q3 2026.
- SEI Investments sold 43,914 Exagen shares in Q3 2026, an estimated $282K.
- Exagen made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2609 holding.
- SEI Investments first reported a position in Exagen in Q4 2025 and has held it in 4 quarters since.
- SEI Investments's Exagen position peaked at $733K in Q1 2026.
- 78 funds tracked by Wall St. Rank held Exagen as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.